Rare Disease Genetic Testing Market | BIS Research
Before the emergence of next-generation sequencing (NGS) technologies such as whole-genome sequencing (WGS) and whole-exome sequencing (WES), rare disease genetic testing relied heavily on Sanger sequencing—a slow, labor-intensive method that often d...
